In a study conducted by Sofikerim et al. (2007) to find the hormonal predictors of the prostate cancer, follicle-stimulating hormone (FSH) was found to be significantly higher in patients with prostate cancer. This evidence concerns the gene BRD2 and Familial prostate cancer.